Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

FATTY ACID BETA DEGRADATION PATHWAY (PW:0000738)

View Ontology Report

Description

The degradation of fatty acids represents an essential source of energy; a major route is the mitochondrial beta-oxidation pathway. Before beta-oxidation can proceed, fatty acids need to be 'primed' or activated. The formation of fatty acyl-CoA thioesters is catalyzed by acyl-CoA synthetases in a two-step reaction. There are several acyl-CoA synthetases named after their chain length specificity. Once activated, acyl-CoAs need to reach the mitochondrial matrix where the enzymes of the beta-oxida

Pathway Diagram:

Ariadne Genomics Inc. NADH Hadha 3-ketoacyl-CoA Acaa2 3-hydroxyacyl-CoA Hadh Echs1 FADH2 CoQ e2 e1 Etfdh Etfb Cpt2 Slc25a20 Acs Cpt1 Acad CoQ ---> oxidative phosphorylation pathway carnitine-in carnitine-out acylcarnitine translocated fatty acyl-CoA Hadhb NAD ---> NADH NAD translocated fatty acyl-CoA ---> trans-2-enoyl-CoA fatty acids ---> fatty acyl-CoA 3-ketoacyl-CoA ---> acyl-CoA - 2C 3-hydroxyacyl-CoA <--> trans-2-enoyl-CoA 3-hydroxyacyl-CoA <--> 3-ketoacyl-CoA trans-2-enoyl-CoA fatty acids fatty acyl-CoA ---> acylcarnitine carnitine-out ---> acylcarnitine carnitine-in ---> carnitine-out acylcarnitine ---> carnitine-in acylcarnitine ---> translocated fatty acyl-CoA FADH2 ---> e1 FADH2 ---> e2 e1 ---> CoQ e2 ---> CoQ acetyl-CoA ---> citrate cycle pathway acetyl-CoA ---> ketone bodies metabolic pathway acyl-CoA - 2C ---> translocated fatty acyl-CoA 3-ketoacyl-CoA ---> acetyl-CoA FAD FAD ---> FADH2 fatty acyl-CoA acetyl-CoA acylcarnitine ---> translocated fatty acyl-CoA citrate cycle pathway ketone bodies metabolic pathway acyl-CoA - 2C Etfa oxidative phosphorylation pathway
GO TO:

Genes in Pathway:


show annotations for term's descendants           Sort by:
fatty acid beta degradation pathway term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcd1 ATP binding cassette subfamily D member 1 ISO SMPDB SMP:00052 NCBI chr  X:151,428,334...151,450,115
Ensembl chr  X:151,428,578...151,450,115
JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 ISO SMPDB SMP:00052 NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 IDA
ISO
SMPDB
RGD
PMID:11879205 SMP:00480 SMP:00481 SMP:00482, RGD:2317624 NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 ISO RGD PMID:14728676 RGD:2317589 NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain ISO
IDA
SMPDB
RGD
PMID:14728676 PMID:3968063 SMP:00480 SMP:00482, RGD:2317589, RGD:2317678 NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain ISO
IDA
SMPDB
RGD
PMID:14728676 PMID:3968063 SMP:00481, RGD:2317589, RGD:2317678 NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
JBrowse link
G Acads acyl-CoA dehydrogenase short chain ISO
IDA
SMPDB
RGD
PMID:14728676 PMID:3968063 SMP:00480, RGD:2317589, RGD:2317678 NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
JBrowse link
G Acadvl acyl-CoA dehydrogenase, very long chain ISO
IMP
RGD PMID:14728676 PMID:15850553 RGD:2317589, RGD:2317683 NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 ISO SMPDB SMP:00480 NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 ISO SMPDB
RGD
PMID:17762044 SMP:00052 SMP:00482, RGD:2317576 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
JBrowse link
G Acsl3 acyl-CoA synthetase long-chain family member 3 ISO RGD PMID:17762044 RGD:2317576 NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 ISO RGD PMID:17762044 RGD:2317576 NCBI chr  X:105,942,794...106,006,573
Ensembl chr  X:105,942,799...106,006,427
JBrowse link
G Acsl5 acyl-CoA synthetase long-chain family member 5 ISO RGD PMID:17762044 RGD:2317576 NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
JBrowse link
G Acsl6 acyl-CoA synthetase long-chain family member 6 ISO RGD PMID:17762044 RGD:2317576 NCBI chr10:38,439,914...38,501,182
Ensembl chr10:38,440,080...38,498,757
JBrowse link
G Acsm1 acyl-CoA synthetase medium-chain family member 1 ISO SMPDB SMP:00481 NCBI chr 1:173,985,715...174,020,565
Ensembl chr 1:173,984,672...174,025,495
JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 ISO RGD PMID:17762044 RGD:2317576 NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 ISO RGD PMID:17762044 RGD:2317576 NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
JBrowse link
G Acsm4 acyl-CoA synthetase medium-chain family member 4 ISO RGD PMID:17762044 RGD:2317576 NCBI chr 1:174,053,931...174,078,345
Ensembl chr 1:174,053,931...174,078,341
JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 ISO RGD PMID:17762044 RGD:2317576 NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 ISO RGD PMID:17762044 RGD:2317576 NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
JBrowse link
G Acss3 acyl-CoA synthetase short-chain family member 3 ISO SMPDB SMP:00480 NCBI chr 7:42,241,261...42,450,209
Ensembl chr 7:42,242,652...42,450,230
JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A TAS
ISO
SMPDB
RGD
PMID:19430727 SMP:00482, RGD:2317584 NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
JBrowse link
G Cpt1b carnitine palmitoyltransferase 1B ISO RGD PMID:19430727 RGD:2317584 NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 TAS
ISO
SMPDB
RGD
PMID:19430727 SMP:00052 SMP:00482, RGD:2317584 NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
JBrowse link
G Crat carnitine O-acetyltransferase ISO SMPDB SMP:00052 NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
JBrowse link
G Crot carnitine O-octanoyltransferase ISO SMPDB SMP:00052 NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
JBrowse link
G Echs1 enoyl-CoA hydratase, short chain 1 IMP
ISO
SMPDB
RGD
PMID:12379132 SMP:00480 SMP:00481 SMP:00482, RGD:2317616 NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
JBrowse link
G Etfa electron transfer flavoprotein subunit alpha ISO RGD PMID:14728676 RGD:2317589 NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
JBrowse link
G Etfb electron transfer flavoprotein subunit beta ISO RGD PMID:14728676 RGD:2317589 NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
JBrowse link
G Etfdh electron transfer flavoprotein dehydrogenase ISO RGD PMID:14728676 RGD:2317589 NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase IMP
ISO
SMPDB
RGD
PMID:17491019 SMP:00480 SMP:00481 SMP:00482, RGD:2302227 NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha ISO SMPDB
RGD
PMID:10816122 SMP:00481 SMP:00482, RGD:2317625 NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
JBrowse link
G Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta ISO SMPDB
RGD
PMID:10816122 SMP:00481 SMP:00482, RGD:2317625 NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
JBrowse link
G Hsd17b10 hydroxysteroid (17-beta) dehydrogenase 10 ISO SMPDB SMP:00480 NCBI chr  X:21,089,142...21,091,603
Ensembl chr  X:21,089,122...21,109,488
JBrowse link
G Pex11g peroxisomal biogenesis factor 11 gamma ISO SMPDB SMP:00052 NCBI chr12:1,502,606...1,532,347
Ensembl chr12:1,503,646...1,512,585
JBrowse link
G Pex13 peroxisomal biogenesis factor 13 ISO SMPDB SMP:00052 NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
JBrowse link
G Pex14 peroxisomal biogenesis factor 14 ISO SMPDB SMP:00052 NCBI chr 5:159,399,776...159,536,260
Ensembl chr 5:159,399,776...159,536,272
JBrowse link
G Slc25a20 solute carrier family 25 member 20 ISO SMPDB
RGD
PMID:19430727 SMP:00052 SMP:00481 SMP:00482, RGD:2317584 NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
JBrowse link

Additional Elements in Pathway:

(includes Gene Groups, Small Molecules, Other Pathways..etc.)
Object TypePathway ObjectPathway Object Description
Gene GroupACSacyl-CoA synthetase members
Gene GroupAcadacyl-Coenzyme A dehydrogenase members
Gene GroupCPT 1carnitine palmitoyltransferase system 1 members

Pathway Gene Annotations

Disease Annotations Associated with Genes in the fatty acid beta degradation pathway
Disease TermsGene Symbols
3-Hydroxyacyl-CoA Dehydrogenase DeficiencyHadh
acute myeloid leukemiaAcsl6
Addison's diseaseAbcd1
adrenoleukodystrophyAbcd1 , Pex13
adult respiratory distress syndromeAcaa2
Aicardi-Goutieres Syndrome 1Slc25a20
Aicardi-Goutieres Syndrome 3Cpt1a
alcohol use disorderAcads
alcoholic hepatitisCpt1a
alkaptonuriaAcad9
Alzheimer's diseaseAcadvl , Hadha , Hadhb , Hsd17b10
amphetamine abuseAcsl6
Animal Disease ModelsAcsl4
Animal Mammary NeoplasmsAcsl1
arteriosclerosisAcat1
arthritisCpt2
asthmaAcsl3
ataxia telangiectasiaAcat1
atherosclerosisCpt1a
Atkin SyndromeHsd17b10
autism spectrum disorderAcadvl , Acsl4 , Cpt1b , Slc25a20
autistic disorderAbcd1 , Acsl4 , Hsd17b10
Autosomal Dominant Intellectual Developmental Disorder 62Acadvl
autosomal hemophilia AAbcd1 , Acsl4
autosomal recessive limb-girdle muscular dystrophy type 2PSlc25a20
azoospermiaHsd17b10
Barth syndromeAbcd1
basal cell carcinomaAcaa2 , Acadl
beta-ketothiolase deficiencyAcat1
Bloom syndromeEtfa
brain diseaseCpt2
breast cancerAcsl3
Breast NeoplasmsCpt1a , Hadhb
carbohydrate metabolic disorderAcat1
carcinomaAcsl1
Cardiac ArrhythmiasAcadvl
Cardiac FibrosisCpt1a
CardiomegalyCpt1b
cardiomyopathyAcsl1
CardiotoxicityCpt1a
Carnitine Acetyltransferase DeficiencyCrat
carnitine palmitoyltransferase I deficiencyCpt1a
carnitine palmitoyltransferase II deficiencyCpt2
Carnitine Palmitoyltransferase II Deficiency, InfantileCpt2
Carnitine Palmitoyltransferase II Deficiency, Lethal NeonatalCpt2
carnitine-acylcarnitine translocase deficiencySlc25a20
cerebral creatine deficiency syndrome 1Abcd1
Charcot-Marie-Tooth diseaseHadhb
Charcot-Marie-Tooth disease type 2Pex14
Charcot-Marie-Tooth disease type 2BAcad9
Chemical and Drug Induced Liver InjuryAcsl1 , Cpt1a , Echs1 , Hadha
chromosome 11 partial duplication syndromeAcat1
chromosome 1p36 deletion syndromePex14
chromosome 22q13 duplication syndromeCpt1b
Chromosome Xq28 Duplication SyndromeAbcd1
Chronic Hepatitis CCpt1a
chronic kidney diseaseEtfb
Chronic PainCpt2
colorectal cancerEtfa
Colorectal NeoplasmsAbcd2
common variable immunodeficiencyAcadvl
congenital disorder of glycosylation IgCpt1b
Congenital Hydrocephalus 2, with or without Brain or Eye AnomaliesAcadm
Congenital HyperinsulinismHadh
congenital myasthenic syndrome 2AAcadvl
congestive heart failureAcads
Cornelia de Lange syndrome 2Hsd17b10
COVID-19Abcd1 , Hadha , Hadhb , Hsd17b10
deafness, dystonia, and cerebral hypomyelinationAbcd1
depressive disorderAcsl4
developmental and epileptic encephalopathyCrat
developmental and epileptic encephalopathy 21Acsm4
developmental and epileptic encephalopathy 25Acadvl
diabetes mellitusCpt1a , Hadh
Diarrhea 13Acsl5
dilated cardiomyopathyAcadvl
disease of metabolismCpt1a , Etfdh
distal 10q deletion syndromeEchs1
dyskeratosis congenitaAbcd1 , Acadvl
dystoniaCrat
early infantile epileptic encephalopathyCrat
Ehlers-Danlos syndrome kyphoscoliotic type 1Abcd1
Emery-Dreifuss muscular dystrophyAbcd1
encephalitisAbcd1
end stage renal diseaseAcat1 , Cpt1a
epilepsyCpt2
ErythemaAcsl4
essential hypertensionAcsm3
Experimental Allergic AsthmaAcsl3
Experimental ArthritisAcsl1 , Acsl4 , Acsl5
Experimental Diabetes MellitusAcadvl , Acsl1 , Acsl3 , Acsl6 , Cpt1a , Cpt1b , Hadh , Hadha
Experimental Liver CirrhosisAcat1 , Acsl1 , Crot
Experimental Mammary NeoplasmsAcsl1
Experimental MelanomaAcss1 , Acss2
factor VIII deficiencyAbcd1 , Acsl4
familial adenomatous polyposis 1Acsl6
familial hyperinsulinemic hypoglycemia 1Hadh
familial hyperinsulinemic hypoglycemia 4Hadh
familial hypertrophic cardiomyopathyAcadvl
Faundes-Banka SyndromeAcadvl
favismAbcd1
Fetal Growth RetardationHadha
FlatfootCpt2
genetic diseaseAbcd1 , Acad9 , Acadm , Acads , Acadvl , Acat1 , Acsl4 , Acsm3 , Cpt1a , Cpt2 , Echs1 , Etfa , Etfb , Etfdh , Hadh , Hadha , Hadhb , Hsd17b10 , Pex13 , Pex14 , Slc25a20
Genu ValgumCpt2
glutaric acidemia IAcadvl
Glutaric Aciduria 2Etfa
glutathione synthetase deficiencyAcss2
glutatione synthetase deficiency with 5-oxoprolinuriaAcss2
heart diseaseHadhb
Heat Stress DisordersAcadvl
hepatocellular carcinomaAcsl4 , Etfa
Hereditary Neoplastic SyndromesAcsl6
hereditary spastic paraplegia 39Pex11g
High MyopiaCpt1b
hyperinsulinemic hypoglycemiaHadh
hyperinsulinismHadh
Hyperphosphatemic Familial Tumoral Calcinosis 1Acsm4
hypertensionAcsm3
hypertrophic cardiomyopathyEtfdh
HypothermiaAcss1
hypothyroidismAbcd2
HypoxiaAcadvl , Cpt1a
IgA glomerulonephritisAcsm3
immunodeficiency 14Pex14
immunodeficiency 21Acad9
immunodeficiency 33Abcd1
infantile Refsum diseasePex13
InflammationAcsl3 , Acsl4 , Acsl6 , Acss2
Insulin ResistanceAcsl1
intellectual disabilityAbcd1 , Acaa2 , Acadvl , Acat1 , Acsl4 , Cpt1a , Cpt1b
Klippel-Feil syndrome 3Acsm4
Late-Onset Carnitine Palmitoyltransferase II DeficiencyCpt2
Left Ventricular HypertrophyCrot
Leigh diseaseEchs1
leukemiaAcsl6
Li-Fraumeni syndromeAcadvl
lipid metabolism disorderCpt1a , Cpt2 , Hadhb
Liver FailureAcadm
Liver NeoplasmsCpt1b
long QT syndromeAcss2
Long-Chain 3-hydroxyacyl-CoA Dehydrogenase DeficiencyAcadl , Hadha , Hadhb
lung adenocarcinomaAcsl4 , Hsd17b10
lung cancerAcsl3
Lung NeoplasmsAcsm1
lymphangioleiomyomatosisAcss2 , Cpt1a
lymphoproliferative syndrome 2Acsm4
maturity-onset diabetes of the young type 1Acads
medium chain acyl-CoA dehydrogenase deficiencyAcadm
megacolonEtfdh
megaconial type congenital muscular dystrophyCpt1b
metabolic acidosisHadhb
Metabolic Brain DiseasesCpt2
metabolic dysfunction-associated steatohepatitisCpt1a
metabolic dysfunction-associated steatotic liver diseaseAcadm , Acadvl , Cpt1a , Hadha
Metabolic SyndromeAcadvl
metachromatic leukodystrophyCpt1b
microcephalyCpt2
mitochondrial complex I deficiencyAcad9
mitochondrial metabolism diseaseHadhb
mitochondrial short-chain enoyl-CoA hydratase 1 deficiencyEchs1
mitochondrial trifunctional protein deficiencyHadha , Hadhb
mitochondrial trifunctional protein deficiency 1Hadha , Hadhb
mitochondrial trifunctional protein deficiency 2Hadhb
morbid obesityAcss2
mucolipidosis type IVPex11g
multiple acyl-CoA dehydrogenase deficiencyEtfa , Etfb , Etfdh
Muscle HypotoniaCpt2
muscular diseaseCpt2
myocardial infarctionHadh
Myocardial IschemiaCpt1b , Hadha
myopathyAcadvl , Cpt2 , Etfdh
narcolepsyCpt1b
nephrotic syndromeAcat1
Nervous System MalformationsAbcd1 , Cpt2
neurodegeneration with brain iron accumulationCrat
Neurodegeneration with Brain Iron Accumulation 8Crat
NEURODEVELOPMENTAL DISORDER WITH SPEECH DELAY AND VARIABLE OCULAR ANOMALIESAcsm3
Neurodevelopmental DisordersAcadl , Acsl3 , Acsl6 , Acsm3
Neurologic Gait DisordersAbcd1
non-syndromic X-linked intellectual disabilityAcsl4
non-syndromic X-linked intellectual disability 1Hsd17b10
non-syndromic X-linked intellectual disability 63Acsl4
nuclear type mitochondrial complex I deficiency 20Acad9
obesityAcadm , Acsl1 , Cpt1a , Echs1 , Etfdh , Hadh
ocular hypertensionAcsm3
orofacial cleftAcss2
osteoarthritisAcaa2 , Etfa , Hadha
osteosarcomaHsd17b10
ovarian cystPex14
OverweightAcsm3
pancytopeniaCpt2
PAPA syndromeEtfa
paraplegiaAbcd1 , Hsd17b10
Pearson syndromeAcadvl
perinatal necrotizing enterocolitisAcadm
periventricular nodular heterotopiaAbcd1
peroxisomal biogenesis disorderPex13 , Pex14
peroxisome biogenesis disorder 11APex13
Peroxisome biogenesis disorder 11BPex13
peroxisome biogenesis disorder 13APex14
peroxisome biogenesis disorder 1APex13 , Pex14
peroxisome biogenesis disorder 2BAbcd1 , Acsm4
Peroxisome Biogenesis Disorder, Complementation Group KPex14
Phelan-McDermid syndromeCpt1b
pheochromocytomaHsd17b10
pleomorphic xanthoastrocytomaCrot
pre-malignant neoplasmHadh
primary coenzyme Q10 deficiency 7Crat
Primary DysautonomiasCpt2
Primary Lymphedema with MyelodysplasiaAcad9
primary pulmonary hypertensionAcadl
Progressive Microcephaly with Seizures and Cerebral and Cerebellar AtrophySlc25a20
prostate cancerAcsl3
Prostatic NeoplasmsAcsl4 , Acsm3
Recurrent Infections, with Encephalopathy, Hepatic Dysfunction, and Cardiovascular MalformationsCpt1a
RhabdomyolysisAcadvl , Cpt2
schizophreniaAcsl6 , Etfa
severe congenital encephalopathy due to MECP2 mutationAbcd1
short chain acyl-CoA dehydrogenase deficiencyAcads
Sinus TachycardiaCpt2
spinal muscular atrophyEtfdh
SplenomegalyAbcd1
StarvationAcsl1
steatotic liver diseaseAcat1 , Hadha , Hadhb
Stomach NeoplasmsEchs1
Sudden Cardiac DeathAcsl3
syndromic X-linked intellectual disability Lubs typeAbcd1 , Acsl4 , Hsd17b10
syndromic X-linked intellectual disability type 10Hsd17b10
systemic primary carnitine deficiency diseaseAcsl6
Tatton-Brown-Rahman syndromeHadha , Hadhb
Temtamy syndromeAcsm4
trichorhinophalangeal syndrome type IAcadl
type 2 diabetes mellitusAcads , Cpt1a
ulcerative colitisAcsm3
very long chain acyl-CoA dehydrogenase deficiencyAcadl , Acadvl
Weight GainAcadm
Weissenbacher-Zweymuller syndromeAcadvl
X-linked spondyloepimetaphyseal dysplasiaAbcd1
Zellweger syndromePex13 , Pex14
Pathway Annotations Associated with Genes in the fatty acid beta degradation pathway
Pathway TermsGene Symbols
2-aminoadipic 2-oxoadipic aciduria pathwayAcat1 , Echs1 , Hadh
3-hydroxy-3-methylglutaryl-CoA lyase deficiency pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
3-hydroxyacyl-CoA dehydrogenase deficiency pathwayAcaa2 , Acadl , Acads , Acat1 , Acss3 , Echs1 , Hadh , Hsd17b10
3-hydroxyisobutyric aciduria pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
3-methylcrotonyl CoA carboxylase 1 deficiency pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
3-methylglutaconic aciduria type 1 pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
3-methylglutaconic aciduria type 3 pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
adenosine monophosphate-activated protein kinase (AMPK) signaling pathwayCpt1a
adrenoleukodystrophy pathwayAbcd1 , Abcd2 , Acsl1 , Cpt2 , Crat , Crot , Pex11g , Pex13 , Pex14 , Slc25a20
Alzheimer's disease pathwayHsd17b10
beta-alanine metabolic pathwayAcadm , Echs1 , Hadha
butanoate metabolic pathwayAcads , Acat1 , Acsm1 , Acsm3 , Acsm4 , Echs1 , Hadh , Hadha
carnitine palmitoyltransferase I deficiency pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Cpt1a , Cpt2 , Echs1 , Hadha , Hadhb
carnitine-acylcarnitine translocase deficiencyAbcd1 , Abcd2 , Acsl1 , Cpt2 , Crat , Crot , Pex11g , Pex13 , Pex14 , Slc25a20
disulfiram pharmacodynamics pathwayAcss1 , Acss2
eicosanoid signaling pathway via peroxisome proliferator-activated receptor gammaAcadl , Acadm , Acsl1 , Acsl3 , Acsl4 , Acsl5 , Acsl6 , Cpt1a , Cpt1b , Cpt2
ethylmalonic encephalopathy pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Cpt1a , Cpt2 , Echs1 , Hadha , Hadhb
fatty acid beta degradation pathwayAbcd1 , Abcd2 , Acaa2 , Acad9 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Acsl3 , Acsl4 , Acsl5 , Acsl6 , Acsm1 , Acsm2 , Acsm3 , Acsm4 , Acss1 , Acss2 , Acss3 , Cpt1a , Cpt1b , Cpt2 , Crat , Crot , Echs1 , Etfa , Etfb , Etfdh , Hadh , Hadha , Hadhb , Hsd17b10 , Pex11g , Pex13 , Pex14 , Slc25a20
fatty acid elongation pathwayAcaa2 , Echs1 , Hadh , Hadha , Hadhb , Hsd17b10
fatty acid metabolic pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Acsl3 , Acsl4 , Acsl5 , Acsl6 , Cpt1a , Cpt1b , Cpt2 , Echs1 , Hadh , Hadha , Hadhb
forkhead class A signaling pathwayAcadm , Acadvl , Cpt1a , Cpt1b , Hadh
gluconeogenesis pathwayAcss1 , Acss2
glutaric aciduria type I pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Cpt1a , Cpt2 , Echs1 , Hadh , Hadha , Hadhb
glycolysis pathwayAcss1 , Acss2
glycolysis/gluconeogenesis pathwayAcss1 , Acss2
glyoxylate and dicarboxylate metabolic pathwayAcat1
hyperlysinemia pathwayAcat1 , Echs1 , Hadh
isobutyryl-CoA dehydrogenase deficiency pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
isovaleric acidemia pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
ketone bodies metabolic pathwayAcat1
Leigh disease pathwayAcat1 , Acss2
lysine degradation pathwayAcat1 , Echs1 , Hadh , Hadha
malonic aciduria pathwayAcadm , Acat1 , Acss1 , Acss3 , Echs1
maple syrup urine disease pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
medium chain acyl-CoA dehydrogenase deficiency pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Cpt1a , Cpt2 , Echs1 , Hadha , Hadhb
methylmalonate semialdehyde dehydrogenase deficiency pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
methylmalonic acidemia pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
methylmalonic aciduria, cobalamin-related pathwayAcadm , Acat1 , Acss1 , Acss3 , Echs1
phytanic acid degradation pathwayAbcd1 , Abcd2
primary hyperoxaluria type 2 pathwayAcat1 , Acss2
propanoate metabolic pathwayAcadm , Acat1 , Acss1 , Acss2 , Acss3 , Echs1 , Hadha
propionic acidemia pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hsd17b10
pyruvate decarboxylase deficiency pathwayAcat1 , Acss2
pyruvate dehydrogenase E1 deficiency pathwayAcat1 , Acss2
pyruvate kinase deficiency of red cells pathwayAcat1 , Acss2
pyruvate metabolic pathwayAcat1 , Acss1 , Acss2
Refsum disease pathwayAbcd1 , Abcd2
saccharopinuria pathwayAcat1 , Echs1 , Hadh
short-chain acyl-CoA dehydrogenase deficiency pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Cpt1a , Cpt2 , Echs1 , Hadha , Hadhb
succinyl-CoA:3-oxoacid transferase deficiency pathwayAcat1
terpenoid biosynthetic pathwayAcat1
trifunctional protein deficiency pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Cpt1a , Cpt2 , Echs1 , Hadha , Hadhb
tryptophan metabolic pathwayAcat1 , Echs1 , Hadh , Hadha
unsaturated fatty acid biosynthetic pathwayHadha
valine, leucine and isoleucine degradation pathwayAcaa2 , Acadm , Acads , Acat1 , Echs1 , Hadh , Hadha , Hadhb , Hsd17b10
valproic acid pharmacokinetics pathwayAcsm1 , Hadha , Hadhb , Hsd17b10
very long-chain acyl-CoA dehydrogenase deficiency pathwayAcaa2 , Acadl , Acadm , Acads , Acadvl , Acat1 , Acsl1 , Cpt1a , Cpt2 , Echs1 , Hadha , Hadhb

References Associated with the fatty acid beta degradation pathway:

Ontology Path Diagram:

paths to the root
paths to the root

Import into Pathway Studio: